The dual mTOR kinase inhibitor TAK228 inhibits tumorigenicity and enhances radiosensitization in diffuse intrinsic pontine glioma
Hiroaki Miyahara(Aichi Medical University), Eric H. Raabe(Johns Hopkins University), Katherine E. Warren(Brigham and Women's Hospital), Charles G. Eberhart(The University of Texas MD Anderson Cancer Center), Manabu Natsumeda(Niigata University), Laura Asnaghi(Johns Hopkins Medicine), Javad Nazarian(Children's National), Jeffrey Rubens(Johns Hopkins University), Harpreet Kaur(Johns Hopkins University), Madhuri Kambhampati(Children's National), Isabella Taylor(Johns Hopkins University), Sridevi Yadavilli(Children's National), Louis Rodgers(National Cancer Institute)
Cited by 68
Related Papers
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711